IMCD NV (CHIX:IMCDA) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:IMCDA IMCD NV CHIX:IMCDA
83 GF Score
Price €79.78
GF Value €141.35
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is IMCD NV Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

CHIX:IMCDA
83GF Score
IMCD NV CHIX:IMCDA
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is IMCD NV (CHIX:IMCDA) Overvalued in 2026?

Based on GuruFocus' analysis, IMCD NV stock appears to be undervalued. The current stock price of €79.78 is trading 43.6% below its estimated GF Value™ of €141.35. GuruFocus considers IMCD NV to be Significantly Undervalued.

Key valuation signals for CHIX:IMCDA:

  • Interest Received:
  • GF Value™: €141.35 vs. price of €79.78 (43.6% below fair value)
  • GF Score™: 83/100 with 5 warning signs

No single metric tells the full story. See the CHIX:IMCDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IMCD NV Business Description

Address Wilhelminaplein 32, Rotterdam, NLD, 3072 DE
IMCD NV is a distributor and formulator of specialty chemicals and ingredients for industrial and life-science markets. The company's product portfolio consists of two categories: Life Science, which consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care I&I, and the Industrial segment, which contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments: EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment, which includes Europe, Turkiye, Israel, Egypt, the United Arab Emirates, Saudi Arabia and Africa.
83GF Score

Get the complete analysis for CHIX:IMCDA

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€79.78
Price
€141.35
GF Value